To determine the expression of TPX2 in different subsets of T cells, we separately isolated CD3+, CD4+, and CD8+ T cells from tumor-infiltrating lymphocytes (TILs) and peripheral blood mononuclear cells (PBMCs) from ten HCC patients. This evidence concerns the gene TPX2 and hepatocellular carcinoma.